Senzime AB (publ)
Senzime AB (publ)
Your view on SNZZF
Overview
What the company does, where it operates, and who runs it.
About Senzime AB (publ)
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Philip Siberg
- Headquarters
- Ulls vAeg 41, Uppsala, SE
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Philip Siberg
- Headquarters
- Ulls vAeg 41, Uppsala, SE
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States.
The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor.
It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver.
Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records.
The company was incorporated in 1999 and is based in Uppsala, Sweden.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Senzime AB (publ) from FRC's valuation model, read against the market price. SNZZF last traded at $0.53; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Senzime AB (publ). Starting points for Senzime AB (publ): EPS -$0.62, beta 0.33 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Senzime AB (publ). Senzime AB (publ) does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Senzime AB (publ). Trailing twelve-month EPS for Senzime AB (publ) stands at -$0.62. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Senzime AB (publ). Senzime AB (publ) has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Medical - Devices companies
Market cap
- ACIXFAcarix AB (publ)OTC$39M
- ADGMAdagio Medical Holdings, Inc.NASDAQ$1M
- ADMTADM Tronics Unlimited, Inc.OTC$7M
- ADR.AXAdherium LimitedASX
- AEMDAethlon Medical, Inc.NASDAQ$3M
- AFIBAcutus Medical, Inc.OTC$5,982
- AHCOAdaptHealth Corp.NASDAQ$1.1B
- ALGNAlign Technology, Inc.NASDAQ$11.7B
- ALRTFALR Technologies Inc.OTC$8M
- ALURAllurion Technologies Inc.OTC$11M
- AMBBYAmbu A/SOTC$3.3B
- AMBFFAmbu A/SOTC$3.7B
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Senzime AB (publ). Coverage tracks Senzime AB (publ) within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Senzime AB (publ).